Pfizer Inc. (NYSE:PFE)

The analysis of economic value added reveals a significant transition from substantial value creation to a period of persistent value destruction. While the initial years showed a strong capacity to generate returns above the cost of capital, a sharp reversal occurred in 2023, leading to negative economic profit that persists through 2025.

Net Operating Profit After Taxes (NOPAT)

A period of extreme volatility is observed in operating profitability. NOPAT peaked in 2022 at 31,018 million US$, representing a significant increase from 2021. However, a precipitous decline followed, resulting in a negative NOPAT of -1,277 million US$ in 2023. Although profitability returned to positive territory in 2024 and 2025, the levels remained substantially lower than the 2021-2022 period, stabilizing around 7,200 million US$.

Invested Capital and Cost of Capital

Invested capital underwent a period of aggressive expansion, rising from 87,670 million US$ in 2021 to a peak of 154,882 million US$ in 2023. This expansion represents a significant increase in the capital base required to generate returns. The cost of capital remained relatively stable, fluctuating within a narrow range between 8.50% and 9.84%, suggesting that the decline in economic profit was driven by operating performance rather than an increase in the required rate of return.

Economic Profit Trends

Economic profit shifted from a high of 20,124 million US$ in 2022 to a deep deficit of -14,443 million US$ in 2023. This shift coincides with the simultaneous collapse of NOPAT and the peak of invested capital. Despite a partial recovery in operating profit in 2024 and 2025, the economic profit remains negative, at -4,344 million US$ and -4,927 million US$ respectively. This indicates that the current operating returns are insufficient to cover the cost of the expanded capital base.

The overall trend indicates a structural challenge where the increase in invested capital has not been matched by a sustainable increase in operating profit. The transition from positive to negative economic profit suggests that the organization is currently destroying shareholder value, as the net operating profit after taxes is failing to meet the minimum threshold required by the cost of capital.

Net income attributable to Pfizer Inc. common shareholders and Net Operating Profit After Taxes (NOPAT) exhibited significant fluctuations between 2021 and 2025. While net income demonstrated an initial increase followed by a substantial decline, NOPAT mirrored this pattern with even more pronounced volatility, including a negative value in 2023.

Net Income Trend

Net income attributable to Pfizer Inc. common shareholders increased from US$21,979 million in 2021 to US$31,372 million in 2022, representing a substantial year-over-year growth. However, a dramatic decrease was observed in 2023, falling to US$2,119 million. A partial recovery occurred in 2024, with net income reaching US$8,031 million, followed by a slight decrease to US$7,771 million in 2025.

NOPAT Trend

NOPAT followed a similar trajectory to net income, increasing from US$18,394 million in 2021 to US$31,018 million in 2022. A significant shift occurred in 2023, with NOPAT becoming negative at US$-1,277 million. A recovery was then seen in 2024, rising to US$7,374 million, and continuing to US$7,193 million in 2025. The magnitude of the decline and subsequent recovery in NOPAT was greater than that observed in net income.

Relationship between Net Income and NOPAT

While both metrics generally moved in the same direction, the divergence in 2023 is noteworthy. The substantial negative NOPAT value suggests that operating profits, after accounting for taxes, were insufficient to cover the cost of capital employed during that year, despite a positive, albeit significantly reduced, net income. This indicates that factors beyond core operational profitability, such as financing or non-operating items, played a larger role in determining net income in 2023.

The period between 2024 and 2025 shows relative stabilization in both metrics, although NOPAT remains considerably lower than its peak in 2022. Further investigation would be required to understand the underlying drivers of these fluctuations and their implications for the company’s long-term financial performance.

The provision for taxes on income exhibits significant volatility over the observed period. Beginning at US$1,852 million in 2021, it increased substantially to US$3,328 million in 2022 before experiencing a dramatic shift to a benefit of negative US$1,115 million in 2023. This benefit continued, albeit at a smaller magnitude, in 2024 (-US$28 million) and 2025 (-US$267 million). In contrast, cash operating taxes demonstrate a more stable, though fluctuating, pattern.

Cash Operating Taxes Trend

Cash operating taxes increased from US$6,137 million in 2021 to US$7,967 million in 2022, representing a substantial rise. A subsequent decrease was noted in 2023, falling to US$2,113 million. Values then recovered somewhat in 2024 and 2025, reaching US$2,426 million and US$2,334 million respectively. While fluctuating, the values in 2024 and 2025 remain considerably below the 2021 and 2022 levels.

The divergence between the provision for taxes on income and cash operating taxes is noteworthy. The large benefit recorded in the provision for taxes in 2023, 2024, and 2025 suggests the utilization of tax loss carryforwards or other tax planning strategies, resulting in a reduced accounting expense despite continued cash outflows for taxes. The cash operating taxes, while decreasing from 2022 to 2023, remained positive throughout the period, indicating actual cash payments were made to tax authorities even when the accounting provision reflected a benefit.

Relationship between Provision and Cash Taxes

The difference between the provision for taxes on income and cash operating taxes widened considerably in 2023, 2024, and 2025. This indicates a growing deferral of taxable income or an increasing benefit from tax credits or loss carryforwards. The substantial difference highlights the impact of non-cash tax items on the reported income tax expense.

The observed trends suggest a complex tax position, potentially involving significant tax planning and the utilization of deferred tax assets. Further investigation into the specific drivers of the tax benefit and the nature of the deferred tax items would be beneficial for a complete understanding of the company’s tax strategy and its impact on financial performance.

The reported invested capital demonstrates a clear increasing trend over the observed period, followed by a stabilization and slight increase. A significant rise is noted between 2021 and 2023, while subsequent years show a more moderate pattern. This analysis details the observed movements in invested capital alongside its constituent components: total reported debt & leases and total shareholders’ equity.

Invested Capital Trend

Invested capital increased substantially from US$87,670 million in 2021 to US$154,882 million in 2023, representing a growth of approximately 76.8%. This growth slowed considerably in 2024, with invested capital decreasing to US$135,342 million. A modest increase to US$139,753 million was observed in 2025. The 2024 decrease suggests a potential shift in capital allocation strategy or a reduction in capital-intensive projects.

Debt & Leases

Total reported debt & leases decreased from US$41,395 million in 2021 to US$39,046 million in 2022. However, a substantial increase occurred in 2023, reaching US$75,041 million. This was followed by a decrease to US$66,993 million in 2024 and a slight increase to US$67,416 million in 2025. The 2023 surge in debt likely contributed significantly to the overall increase in invested capital during that year.

Shareholders’ Equity

Total shareholders’ equity increased from US$77,201 million in 2021 to US$95,661 million in 2022, indicating strong equity growth. A decrease was then observed in 2023, falling to US$89,014 million, and continued to decline in 2024 and 2025, reaching US$88,203 million and US$86,476 million respectively. This consistent decline in shareholders’ equity over the latter part of the period partially offset the impact of increased debt on invested capital.

The interplay between debt and equity significantly influences the overall invested capital. While debt increased substantially in 2023, the subsequent decrease in shareholders’ equity moderated the growth in invested capital in 2024 and 2025. The stabilization of invested capital in the later years suggests a balancing act between debt financing and equity returns.

The financial trajectory between 2021 and 2025 reflects a period of significant volatility in value creation, characterized by a sharp peak in economic performance followed by a transition into persistent value destruction. The transition from positive economic profit to negative returns indicates that the returns generated on invested capital have fallen below the company's cost of capital starting in 2023.

Economic Profit

A substantial increase in economic profit is observed between 2021 and 2022, where the figure rose from 9,940 million US$ to a peak of 20,124 million US$. However, a severe reversal occurred in 2023, with economic profit collapsing to -14,443 million US$. While there was a partial recovery in 2024 to -4,344 million US$, the figure declined again in 2025 to -4,927 million US$, confirming a sustained period of negative economic profit.

Invested Capital

Invested capital exhibited a consistent upward trend from 2021 through 2023, growing from 87,670 million US$ to a peak of 154,882 million US$. This expansion represents a significant increase in the capital base. A reduction followed in 2024 to 135,342 million US$, with a subsequent slight increase to 139,753 million US$ by 2025, suggesting a stabilization of the capital structure following the 2023 peak.

Economic Spread Ratio

The economic spread ratio mirrors the volatility of economic profit, peaking at 18.17% in 2022. A drastic contraction occurred in 2023, with the ratio falling to -9.33%, signaling that the company began destroying shareholder value. Although the ratio improved to -3.21% in 2024 and remained relatively stable at -3.53% in 2025, the continued negative values indicate that the company has been unable to generate a return sufficient to cover its cost of capital for three consecutive years.

The correlation between the surge in invested capital through 2023 and the subsequent collapse in the economic spread ratio suggests that the capital expansions did not yield the expected proportional returns. The inability to return to a positive spread ratio by 2025 highlights a persistent gap between the cost of funding and the operational returns on the assets deployed.

The analysis of economic profitability indicates a period of significant value creation followed by a sharp reversal and sustained economic value destruction over the observed five-year window.

Revenue Trajectory

Revenues experienced a peak in 2022 at US$ 101,175 million, marking an increase from the 2021 level of US$ 82,145 million. A substantial contraction occurred in 2023, with revenues declining to US$ 59,553 million. For the subsequent years, revenue levels reached a state of relative stability, fluctuating between US$ 63,627 million in 2024 and US$ 62,579 million in 2025.

Economic Profit Performance

Economic profit grew significantly from US$ 9,940 million in 2021 to US$ 20,124 million in 2022, indicating a period where returns substantially exceeded the cost of capital. This trend reversed abruptly in 2023, resulting in an economic loss of US$ 14,443 million. Although the economic deficit narrowed to US$ 4,344 million in 2024, it widened again to US$ 4,927 million in 2025, showing a persistent inability to generate positive economic value.

Economic Profit Margin Trends

The economic profit margin followed a volatile path, expanding from 12.10% in 2021 to a peak of 19.89% in 2022. The most severe downturn occurred in 2023, with the margin falling to -24.25%. A partial recovery was observed in 2024 as the margin improved to -6.83%, but this progress was offset in 2025 as the margin declined further to -7.87%, underscoring a continuing trend of negative value creation relative to total revenue.